A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1998
10/06/1998	US5817493 Lipases immobilized in sol-gel processed hydrophobic materials
10/06/1998	US5817364 High energy drink
10/06/1998	CA2136841C Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
10/04/1998	CA2233925A1 Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
10/01/1998	WO1998042749A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998	WO1998042747A1 Polypeptide with appetite regulating activity
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042704A1 Improved method for producing thiazolidinediones, and new thiazolidinediones
10/01/1998	WO1998042686A1 Ldl receptor gene expression promoters
10/01/1998	WO1998042368A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
10/01/1998	WO1998042367A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
10/01/1998	WO1998042340A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
10/01/1998	WO1998024422A3 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284192A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
10/01/1998	CA2283705A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998	CA2232461A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/1998
09/30/1998	EP0867436A1 N-aryl-piperidine derivatives and their use as 5-HT1B receptor ligands
09/30/1998	EP0867175A1 Complexes of gamma-cyclodextrins and retinol or retinol-derivatives and manufacturing process thereof and their use
09/30/1998	EP0866874A1 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
09/30/1998	EP0866801A1 Cyclopeptolides
09/30/1998	EP0866722A1 Improved formulation for administration of steroid compounds
09/30/1998	EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions
09/30/1998	EP0866691A1 Sublingual and buccal administration of selegiline
09/29/1998	US5814663 Adminstering to a human a specific dosage of conjugated linoleic acid
09/29/1998	US5814661 Treatment of shock and reducing tumor necrosis factor
09/29/1998	US5814654 Treatment of hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia, cerebro-ischemic disorders, cell proliferation, endothelial cell injury
09/29/1998	US5814607 Pulmonary delivery of active fragments of parathyroid hormone
09/29/1998	CA2101775C Method of reducing elevated blood sugar levels in humans
09/24/1998	WO1998041528A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998	WO1998041519A1 Novel cannabinoid receptor agonists
09/24/1998	WO1998041508A1 Substituted isoquinoline derivatives and their use as anticonvulsants
09/24/1998	WO1998041232A2 Compositions for modulating responsiveness to corticosteroids
09/24/1998	WO1998041216A1 Composition for prevention of hepatic steatosis
09/24/1998	WO1998041201A1 Therapeutic compositions
09/24/1998	WO1998041200A1 Therapeutic compositions
09/24/1998	DE19711616A1 Verbessertes Verfahren zur Herstellung von Thiazolidindionen An improved process for the preparation of thiazolidinediones
09/24/1998	CA2284218A1 Substituted isoquinoline derivatives and their use as anticonvulsants
09/24/1998	CA2283797A1 Novel cannabinoid receptor agonists
09/24/1998	CA2283438A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998	CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids
09/23/1998	EP0866125A1 Novel protein hmw human mp52
09/23/1998	EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis
09/23/1998	EP0865428A1 Vitamin d analogues
09/23/1998	EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
09/23/1998	EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors
09/23/1998	EP0865294A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions
09/23/1998	EP0865288A2 Bioartificial devices and cellular matrices therefor
09/23/1998	EP0714240B1 Reduced absorption of fatty acids
09/23/1998	EP0527232B1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof
09/23/1998	EP0526658B1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same
09/23/1998	CN1193973A £1,2,4\| triazolo £4,3-a\| quinoxalinone derivatives, their preparation and use
09/23/1998	CN1193907A Preparation and methods for the treatment of T cell mediated diseases
09/23/1998	CN1193894A Two-stage preparation
09/23/1998	CN1193889A Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions methods and kits
09/23/1998	CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
09/23/1998	CN1193513A Use of pyrimidine derivatives for prevention of cancer, on their own or in combination with other therapeutic measures
09/22/1998	US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis
09/22/1998	US5811553 Quinoline derivatives(2)
09/22/1998	US5811549 Process of preparing imidazole compounds
09/22/1998	US5811445 Angiotensin ii inhibitors
09/22/1998	US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds
09/22/1998	US5811439 Antidiabetic agents; side effect reduction; antilepemic agents
09/22/1998	US5811437 Treating cardiovascular disorder, gastrointestinal disorder, nervous system disorder related to reduced endothelial nitric oxide production
09/22/1998	US5811436 Complexed with amberlite irp-88; administering to treat or prevent mixed anxiety and depression
09/22/1998	US5811429 Bicyclic heterocyclic compounds
09/22/1998	US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
09/22/1998	US5811415 Lipophilic benzothiophenes
09/22/1998	US5811266 Methods for producing human insulin
09/22/1998	CA2138367C Use of phosphonates for the treatment of osteoporosis
09/22/1998	CA2138366C Methods for the treatment of arthritis using phosphonates and nsaids
09/22/1998	CA2131000C Indoles
09/17/1998	WO1998040406A1 Calcium phosphopeptide complexes
09/17/1998	WO1998040386A1 Dioxino derivatives and their use as therapeutic agents
09/17/1998	WO1998040385A1 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
09/17/1998	WO1998040375A2 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
09/17/1998	WO1998040353A1 Novel heterocyclic compounds
09/17/1998	WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
09/17/1998	WO1998040049A2 Specific magnetosome, method for the production and use thereof
09/17/1998	WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells
09/17/1998	WO1998030455A3 Method and bottle for infant feeding
09/17/1998	WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal
09/17/1998	CA2727634A1 Calcium fluoride phosphate complexes
09/17/1998	CA2283575A1 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and hmg co-a reductase inhibitors
09/17/1998	CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
09/16/1998	EP0864582A2 Hypolipidemic 1,4-benzothiazepine-1,-dioxides
09/16/1998	EP0864327A1 Use of pyrimidin derivatives to prevent cancer
09/16/1998	EP0863892A1 Lipophilic benzothiophenes
09/16/1998	EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases
09/16/1998	EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof
09/16/1998	EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
09/16/1998	EP0728128B1 Substituted phenyl compounds
09/16/1998	EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties
09/16/1998	EP0570380B1 Novel methylenebisphosphonic acid derivatives
09/16/1998	CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives
09/16/1998	CN1193325A Cell adhension inhibitors
09/16/1998	CN1193313A Propynyl or dienyl diaromatic compounds
09/16/1998	CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist
09/16/1998	CN1192926A Formula of glagctogogue powder and preparation method therefor
09/15/1998	US5808061 Intermediates and processes for preparing benzothiophene compounds

1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 1298